Japan could become one of the first countries in the world to end the HIV epidemic, says the president of Gilead Sciences Japan, Kennet Brysting. The idea for now could seem a little too ambitious, but it is not entirely unrealistic, given that the availability of medicines that can prevent transmission of HIV. Drugs are not the cure, but control over the spread of virus to the point where the disease is no longer a major public health threat.

What Is The Role Of Preventative HIV Medicines?

Gilead's have two key drugs, Truvada and lenacapavir. These two are playing a crucial role in prevention. Truvada is taken as a daily pill, while lenacapavir requires two injections per year. It can make the virus undetectable in infected individuals and prevent transmission to those who are not infected yet. In trials, lenacapavir showed 100% efficacy in preventing HIV infections. This is why it is describe as "almost a vaccine".

In 2024, Japan also approved Truvada for HIV prevention, but the country has yet to approve lenacapavir for the same. Until now, people in Japan had been importing generic versions of Truvada or purchasing it from clinics that source it from overseas.

HIV In Japan

Up until now, Japan reported around 25,000 HIV infections, whereas 669 new cases were reported in 2023. For seven consecutive years, the number of new infections remained under 1,000. The downward trend thus shows that the virus has been controlled, however, getting to zero new infections remains the ultimate goal.

Brysting too acknowledged that simply having effective drug is not enough. What is important is to have a proper implementation, access and healthcare support to make sure that these treatments are widely available and effective.

What Are The Challenges In Implementation?

The biggest challenges is testing rates. There is a need to increase testing rates. At this very moment, around 86% people infective with Japan have been tested, but the goal is to increase it up to 95%, with an ideal goal of 100%. Without widespread testing, many infected people may not even know that they are infected and it could transmit the virus.

Another measure issue is the cost of preventative medication. While Japan's health insurance covers treatments for diseases, it does not cover preventative drugs. Those who purchase Truvada for prevention, pay around $470 per month. Some clinics in Tokyo offer generic alternatives too, which is cheaper, but they are not ideal.

Better Healthcare Support

Brysting expressed concern that individuals importing medications might not be consulting doctors regularly, which is essential for monitoring HIV status and overall health. Truvada users need to be tested for HIV initially and every three months, along with screenings for other infections and kidney function checks. Without proper medical supervision, there is a risk of misuse and inadequate protection.

Gilead is in discussions with Japanese authorities to improve access and insurance coverage for Truvada, and progress is being made. Japan has shown efficiency in approving critical medicines, as seen during the COVID-19 pandemic when Gilead’s remdesivir was approved in just three days.

What Is The Way Ahead?

Gilead at this moment is not only focused on HIV and hepatitis C, but also expanding into oncology with innovative treatments like CAR-T cell therapy, which strengthens a patient's immune system to fight cancer.

However, Japan’s strict approval processes can slow down drug availability. Phase 3 clinical trials often need to be conducted within the country, and Japan tends to approve medicines much later than other regions. For instance, Truvada was approved for prevention in Japan 12 years after the U.S. and nearly 20 years after its approval for treatment. inancial factors also play a role. The Japanese government adjusts drug prices annually, often reducing them, which can make long-term investment challenging for pharmaceutical companies.

Amid the scare of hantavirus infection, US health officials informed that they are investigating a potential case in an Illinois resident.

The Illinois Department of Public Health (IDPH) noted that the incident is not linked to the MV Hondius cruise ship outbreak.

MV Hondius had 18 American nationals, and all have been medically evacuated back to the US. While 16 people are in Nebraska at the nation's only national quarantine unit, two people are being monitored in Atlanta.

In a statement, the IDPH said that the person “lives in Winnebago County, has not travelled internationally, and has not come in contact with individuals associated with the MV Hondius outbreak”.

Officials suspect that the possible hantavirus infection in the Illinois person to be a case of the North American strain of the virus while cleaning a home where rodent droppings were present.

“Unlike the Andes strain of Hantavirus responsible for the cruise outbreak, the North American strains are not known to spread from person to person. The risk of contracting Hantavirus of any kind remains very low for Illinois residents,” the officials said.

However, they added that the CDC is conducting additional testing to confirm that the resident is positive for Hantavirus. CDC staff told IDPH its confirmatory test result could take up to 10 days to complete.

Hantavirus Cases In The US

Excluding this latest potential case, Illinois has had 7 positive cases of Hantavirus since 1993, most recently in March 2025.

Since surveillance began in 1993, the US has recorded 890 cases of Hantavirus over 30 years (1993-2023)

The Hantavirus strain most commonly seen in the US is caused by exposure to rodent droppings and is NOT contagious from person to person.

The rodent species (long-tailed pygmy rice rat) known to carry the Andes strain of the virus in South America does not live in the U.S.

First Case Of Hantavirus Diagnosed In Israel

Also read: Donald Trump Says Hantavirus Is 'Under Control'; Questions Grow Over CDC Research Cuts

Earlier, a case of hantavirus was also reported from Israel, that was not linked to the MV Hondius ship.

The case in Israel, reported by the local newspaper Maariv, is believed to have been infected during a stay in Eastern Europe several months ago. It is reportedly not linked to the ongoing outbreak linked to the MV Hondius cruise ship in the Atlantic Ocean.

The patient underwent an antibody test after the symptoms appeared, which showed exposure to hantavirus, the report said. A PCR (polymerase chain reaction) test was then conducted to detect the virus’s genetic material, confirming the infection, the report said.

The patient was said to be in stable condition, not in need of intensive care or strict isolation, and was being kept under medical observation.

Details about the patient and the medical center where the diagnosis was made could not yet be published, but have been reported to the country's Health Ministry.

Will Hantavirus Become A Public Health Threat?

Also read: Fact Check: Can Ivermectin Help Treat Hantavirus?

Hantavirus is primarily transmitted through contact with infected rodents or exposure to their urine, droppings, and saliva, though rare cases of person-to-person transmission have also been reported.

According to the World Health Organization (WHO), 11 cases — including three deaths — have been confirmed so far. However, additional suspected and confirmed cases are continuing to emerge across countries.

“At the moment, there is no sign that we are seeing the start of a larger outbreak,” said Tedros Adhanom Ghebreyesus, WHO Chief, in the latest media briefing.

However, he said that the situation could still change.

“Given the long incubation period of the virus, we might see more cases in the coming weeks,” he said.

Polycystic Ovary Syndrome (PCOS), a condition affecting more than 170 million women worldwide, has now been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS), according to a global study published today in The Lancet.

The new name reflects a major shift in understanding the condition — from being viewed primarily as a gynecological disorder to being recognized as a complex, multisystem condition affecting several aspects of health.

The new term PMOS acknowledges that the condition involves:

• Endocrine health
• Metabolic health
• Reproductive health
• Dermatological health
• Psychological health

“For too long, the narrow definition of PCOS has overlooked its metabolic and hormonal complexity, leaving many patients undiagnosed or misunderstood,” Cree added.

Why Was PCOS Renamed To PMOS?

Calls to rename PCOS date back to the 1990s and early 2000s. In 2012, the U.S. National Institutes of Health (NIH) recommended a name change after experts concluded that the term PCOS was misleading and confusing for both patients and healthcare providers.

“The name focuses on a criterion — polycystic ovarian morphology — which is neither necessary nor sufficient to diagnose the syndrome,” NIH experts wrote in the report.

Although PCOS has long been understood as a metabolic condition, experts said the name inaccurately narrowed its scope and overemphasized ovarian cysts and fertility issues.

This often led to:

• Delayed diagnoses
• Fragmented care
• Stigma
• Missed opportunities for early intervention

How Was The Name Change Decided?

The renaming process involved consultations with thousands of patients and healthcare professionals across the world.

The effort was supported by 56 academic, clinical, and patient organizations.

Experts said the transition from PCOS to PMOS will occur over the next three years through a phased global implementation strategy.

What Does PMOS Mean?

The new name aims to explain the condition more accurately and comprehensively.

Polyendocrine means it affects multiple hormones in the body.

Metabolic refers to issues linked to weight, insulin, blood sugar, and heart health.

Ovarian highlights its impact on ovulation and reproductive health.

Syndrome refers to a group of symptoms occurring together.

In simple terms, PMOS is a hormonal and metabolic condition that can affect periods, fertility, skin, mood, weight, and long-term health.

Experts said the new terminology intends to:

• Reflect the condition’s hormonal complexity
• Acknowledge its strong metabolic and cardiometabolic effects
• Continue emphasizing ovarian involvement without over-focusing on fertility

According to the study, PMOS could also:

• Promote earlier and more accurate diagnosis
• Support more holistic, patient-centered care
• Reduce stigma associated with fertility-focused terminology
• Expand research into metabolic and systemic impacts

Hantavirus cases have climbed to 11, including three deaths, WHO Director-General Tedros Adhanom Ghebreyesus said today.

During a media briefing on hantavirus, Tedros stated that all eleven cases are among passengers or crew members onboard the MV Hondius.

Also Read: Hantavirus Can Linger Indoors, Spread Through Contaminated Dust, Says Infectious Disease Expert

“Nine of the eleven have been confirmed as Andes virus, and the other two are probable,” he added.

All suspected and confirmed cases have been isolated and managed under strict medical supervision, minimizing any risk of further transmission.

Tedros said individual countries were now responsible for their citizens after the evacuation, adding: “I hope they will take care of the patients and the passengers, helping them and also protecting their citizens as well. That’s what we expect.”

Will Hantavirus Become A Public Health Threat?

Noting that “at the moment, there is no sign that we are seeing the start of a larger outbreak,” Tedros said the situation could still change.

“Given the long incubation period of the virus, it’s possible we might see more cases in the coming weeks,” he said.

Acclaimed vaccine scientist Prof. Peter Hotez from the Texas Medical Center (TMC) also said more cases could emerge, but ruled out the risk of a major epidemic.

“We might see additional cases, but I don't think this will be a major epidemic beyond the obvious human tragedy of those who lost their lives, and possibly a few others who could still get very sick,” he said in a post on social media platform X.

“New World hantavirus infections are rough stuff. Once symptoms begin, the resulting cytokine storm and ARDS means there's not much of a window before getting patients into an ICU, and often on ECMO (extracorporeal membrane oxygenation), which requires a high level of skill,” Prof. Peter said.

He also linked increasing zoonotic spillovers and rising arthropod-borne illnesses to “climate change pushing animal reservoirs to explore new habitats, together with deforestation and urbanization.”

“It's animals and vectors closer to humans and people coming closer to animals and vectors,” he added.

“I don't think this particular hantavirus outbreak will accelerate much beyond where it is now, but that's not the point.”

Dutch Hospital Quarantines 12 Healthcare Workers

Meanwhile, Radboud University Medical Center (Radboudumc) in the Netherlands has placed 12 employees in quarantine for six weeks as a precaution after incorrect procedures were followed while caring for a hantavirus-infected patient from the Dutch cruise ship.

The hospital said on Monday that the issue involved procedures for drawing and processing blood samples, as well as the disposal of the patient's urine, according to Xinhua news agency.

Also read: Fact Check: Can Ivermectin Help Treat Hantavirus?

“This blood was processed according to standard procedure. Due to the nature of the virus, this blood should have been processed according to a stricter procedure,” Radboudumc said in a statement, without specifying what the stricter measures should have entailed.

Read More: Donald Trump Says Hantavirus Is 'Under Control'; Questions Grow Over CDC Research Cuts

WHO Guidelines On Hantavirus

The WHO recommends that people exposed to hantavirus should be:

• Monitored actively at a specified quarantine facility
• Monitored at home for 42 days from the last exposure